Five-Year Clinical Effect of Coronary Stenting and Coronary Artery Bypass Grafting in Renal Insufficient Patients With Multivessel Coronary Artery Disease: Insights From ARTS Trial

Aoki, Jiro; Ong, Andrew T.L.; Hoye, Angela

doi:10.1016/j.accreview.2005.11.073

Cited by 6 publications

(7 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, CABG was associated with a reduced risk of repeat revascularisation (PCI n = 38 (25%); CABG n = 11 (8%); hazard ratio 0.28, p < 0.01). A further analysis has since confirmed these findings out to five years (Aoki et al 2005). Predictably, CKD was associated with a nearly twofold risk for the primary endpoint compared to those with normal renal function.…”

Section: Optimal Revascularisation Strategy Pci Versus Cabgsupporting

confidence: 58%

Coronary Revascularisation in Chronic Kidney Disease Part 1: Stable Coronary Artery Disease

Seddon¹,

Curzen²

2010

Journal of Renal Care

View full text Add to dashboard Cite

Chronic kidney disease (CKD) is associated with a high burden of coronary artery disease, myocardial infarction and cardiovascular death. Detection and treatment of coronary artery disease in CKD patients has been hampered by the limitations of screening tests, the lack of direct evidence for therapeutic interventions in this specific population, and concerns about therapy-related adverse effects. However, these patients potentially have much to gain from conventional strategies used in the general population. This review summarises the current evidence regarding the treatment of coronary artery disease in patients with CKD, with the focus on coronary revascularisation by percutaneous coronary intervention or coronary artery bypass grafting.

show abstract

Section: Optimal Revascularisation Strategy Pci Versus Cabgsupporting

confidence: 58%

Coronary Revascularisation in Chronic Kidney Disease Part 1: Stable Coronary Artery Disease

Seddon¹,

Curzen²

2010

Journal of Renal Care

View full text Add to dashboard Cite

show abstract

“…Trials to compare different treatment strategies for CAD among patients with CKD are lacking. Most studies are registry-based [8] or subanalyses from randomized clinical trials, such as MASS (Medicine, Angioplasty, or Surgery Study) II [5], BARI (Bypass Angioplasty Revascularization Investigation) [9], and ARTS (Arterial Revascularization Therapies Study) [10]. Results are conflicting, and there is no consensus for the best treatment option for CAD among the CKD population.…”

mentioning

confidence: 99%

Impact of Chronic Kidney Disease on Long-Term Outcomes in Type 2 Diabetic Patients With Coronary Artery Disease on Surgical, Angioplasty, or Medical Treatment

Lima

Hueb

Gersh

et al. 2016

The Annals of Thoracic Surgery

View full text Add to dashboard Cite

show abstract

“…[1][2][3][4][5][6][7][8][9][10][11][12][13][14] Myocardial perfusion singlephoton emission CT (MPS) has been validated as a powerful prognostic tool for predicting adverse cardiovascular outcomes in patients with known or suspected coronary artery disease (CAD). [15][16][17][18][19] Although a large proportion of patients undergoing stress MPS have some degree of renal dysfunction, the prognostic value of MPS in the risk stratification of this cohort has not been investigated.…”

mentioning

confidence: 99%

Predictive Value of Myocardial Perfusion Single-Photon Emission Computed Tomography and the Impact of Renal Function on Cardiac Death

et al. 2008

View full text Add to dashboard Cite

Background-Patients with chronic kidney disease (CKD) have worse cardiovascular outcomes than those without CKD. The prognostic utility of myocardial perfusion single-photon emission CT (MPS) in patients with varying degrees of renal dysfunction and the impact of CKD on cardiac death prediction in patients undergoing MPS have not been investigated. Methods and Results-We followed up 1652 consecutive patients who underwent stress MPS (32% exercise, 95% gated) for cardiac death for a mean of 2.15Ϯ0.8 years. MPS defects were defined with a summed stress score (normal summed stress score Ͻ4, abnormal summed stress scoreՆ4). Ischemia was defined as a summed stress score Ն4 plus a summed difference score Ն2, and scar was defined as a summed difference score Ͻ2 plus a summed stress score Ն4. Renal function was calculated with the Modified Diet in Renal Disease equation. CKD (estimated glomerular filtration rate Ͻ60 mL · min Ϫ1 · 1.73 m Ϫ2 ) was present in 36%. Cardiac death increased with worsening levels of perfusion defects across the entire spectrum of renal function. Presence of ischemia was independently predictive of cardiac death, all-cause mortality, and nonfatal myocardial infarction. Patients with normal MPS and CKD had higher unadjusted cardiac death event rates than those with no CKD and normal MPS (2.7% versus 0.8%, Pϭ0.001). Multivariate Cox proportional hazards models revealed that both perfusion defects (hazard ratio 1.90, 95% CI 1.47 to 2.46) and CKD (hazard ratio 1.96, 95% CI 1.29 to 2.95) were independent predictors of cardiac death after accounting for risk factors, left ventricular dysfunction, pharmacological stress, and symptom status. Both MPS and CKD had incremental power for cardiac death prediction over baseline risk factors and left ventricular dysfunction (global 2 207.5 versus 169.3, PϽ0.0001). Conclusions-MPS

show abstract

Five-Year Clinical Effect of Coronary Stenting and Coronary Artery Bypass Grafting in Renal Insufficient Patients With Multivessel Coronary Artery Disease: Insights From ARTS Trial

Cited by 6 publications

References 28 publications

Coronary Revascularisation in Chronic Kidney Disease Part 1: Stable Coronary Artery Disease

Coronary Revascularisation in Chronic Kidney Disease Part 1: Stable Coronary Artery Disease

Impact of Chronic Kidney Disease on Long-Term Outcomes in Type 2 Diabetic Patients With Coronary Artery Disease on Surgical, Angioplasty, or Medical Treatment

Predictive Value of Myocardial Perfusion Single-Photon Emission Computed Tomography and the Impact of Renal Function on Cardiac Death

Contact Info

Product

Resources

About